[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100540271":3},{"organization":4,"armGroups":7,"interventions":27,"overallOfficials":56,"centralContacts":60,"locations":66,"responsibleParty":86,"collaborators":89,"id":93,"slug":94,"hasResults":95,"nctId":96,"briefTitle":97,"officialTitle":98,"acronym":33,"eligibilityCriteria":99,"healthyVolunteers":100,"sex":101,"minAge":33,"maxAge":33,"enrollmentInfo":102,"targetDuration":33,"studyType":105,"phases":106,"briefSummary":108,"conditions":109,"keywords":33,"overallStatus":68,"whyStopped":33,"lastUpdateSubmitDate":112,"lastUpdatePostDateStruct":113,"startDateStruct":116,"completionDateStruct":118,"leadSponsor":120,"locationsCount":121},{"fullName":5,"class":6},"Ohio State University Comprehensive Cancer Center","OTHER",[8,19,23],{"label":9,"type":10,"description":11,"interventionNames":12},"Phase I (interview, discussion, review, AEP, education)","EXPERIMENTAL","Community members, clinic staff, and providers undergo in-depth interview for intervention development on study. Researchers review baseline data on referral patterns and accrual of racial and ethnic minorities to clinical trials in each clinic site. Providers, clinical staff, and research team participate in implementation discussion. AEP strategies developed and initiated in one OSUCCC\u002FJames clinic. Providers and community members participate in educational sessions on study. (Year 1)",[13,14,15,16,17,18],"Procedure: Accrual","Procedure: Discussion","Other: Educational Activity","Other: Interview","Other: Review","Other: Survey Administration",{"label":20,"type":10,"description":21,"interventionNames":22},"Phase II (AEP, education, interviews)","Participants participate in the AEP in the remaining clinics at OSUCCC\u002FJames and community clinics on study. Community members and providers participate in culturally tailored educational activities. Providers, patients, and community members participate in interviews to explore current barriers to referral and participation on study. (Years 2-4)",[13,15,16,18],{"label":24,"type":10,"description":25,"interventionNames":26},"Phase III (interview)","Providers, clinic staff, patients, and community members participate in interviews to explore current barriers to referral and participation. (Year 5)",[16],[28,34,40,44,48,52],{"type":29,"name":30,"description":31,"armGroupLabels":32,"otherNames":33},"PROCEDURE","Accrual","Participate in AEP",[9,20],null,{"type":29,"name":35,"description":36,"armGroupLabels":37,"otherNames":38},"Discussion","Participate in implementation discussions",[9],[39],"Discuss",{"type":6,"name":41,"description":42,"armGroupLabels":43,"otherNames":33},"Educational Activity","Participate in educational sessions\u002Factivities",[9,20],{"type":6,"name":45,"description":46,"armGroupLabels":47,"otherNames":33},"Interview","Undergo interview",[9,20,24],{"type":6,"name":49,"description":50,"armGroupLabels":51,"otherNames":33},"Review","Undergo data capture review",[9],{"type":6,"name":53,"description":54,"armGroupLabels":55,"otherNames":33},"Survey Administration","Ancillary studies",[9,20],[57],{"name":58,"affiliation":5,"role":59},"Electra D Paskett, PhD","PRINCIPAL_INVESTIGATOR",[61],{"name":62,"role":63,"phone":64,"phoneExt":33,"email":65},"The Ohio State Comprehensive Cancer Center","CONTACT","800-293-5066","OSUCCCClinicaltrials@osumc.edu",[67],{"facility":5,"status":68,"city":69,"state":70,"zip":71,"country":72,"countryCode":73,"cosmosGeoPoint":74,"geoPoint":79,"contacts":80},"RECRUITING","Columbus","Ohio","43210","United States","US",{"type":75,"coordinates":76},"Point",[77,78],-82.99879,39.96118,{"lat":78,"lon":77},[81,85],{"name":82,"role":63,"phone":83,"phoneExt":33,"email":84},"Electra D. Paskett, PhD","614-293-3917","electra.paskett@osumc.edu",{"name":82,"role":59,"phone":33,"phoneExt":33,"email":33},{"type":59,"investigatorFullName":87,"investigatorTitle":88,"investigatorAffiliation":5,"oldNameTitle":33,"oldOrganization":33},"Electra Paskett","Principal Investigator",[90],{"name":91,"class":92},"National Cancer Institute (NCI)","NIH","100540271","outreach-project-to-connect-underrepresented-populations-to-clinical-trials-at-ohio-state-university-cusp2ct-project-trial-100540271",false,"NCT06314672","Outreach Project to Connect Underrepresented Populations to Clinical Trials at Ohio State University, CUSP2CT Project Trial","The Ohio State University Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) Project","Inclusion Criteria:\n\n* Phase I: 9 counties in the OSUCCC catchment area\n* Phase II: Patients, providers, and hospital systems\u002Freferral centers that directly addresses challenges identified in Phase I\n* Phase II: The project will involve the OSUCCC, the OSU James Cancer Network sites and the Columbus and Dayton NCORP sites",true,"ALL",{"count":103,"type":104},208,"ESTIMATED","INTERVENTIONAL",[107],"NA","This clinical trial tests the impact of the The Ohio State University Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) project on clinical trial referrals and enrollment in racial\u002Fethnic minorities. Progress in cancer prevention, detection and treatment can only be made by identifying and validating new and improved methods, compounds and modalities in clinical trials. Unfortunately, participation in clinical trials is not equal across all racial and ethnic groups, limiting progress against cancer in all population groups and further widening the disparity gap. To change this picture, concerted effort needs to be directed both at the communities at risk for being left out of trials and the systems that cause the disparities at all levels involved in accrual to clinical trials. The CUSP2CT project may have the potential to increase referral and accrual of racial\u002Fethnic minorities to prevention\u002Fcontrol and treatment trials.",[110,111],"Hematopoietic and Lymphoid System Neoplasm","Malignant Solid Neoplasm","2026-06-05",{"date":114,"type":115},"2026-06-09","ACTUAL",{"date":117,"type":115},"2023-08-22",{"date":119,"type":104},"2028-12-31",{"name":5,"class":6},1]